Earlier this week, BIA member company Modern Biosciences announced it has entered into a collaboration with Janssen to develop their novel bone-protective compounds for the treatment of rheumatoid arthritis. The collaboration was facilitated by another BIA member company, Johnson & Johnson Innovation.
There are four Johnson & Johnson Innovation Centres located across the globe in Boston, California, London and Shanghai. The Innovation Centres were created to access the best science and technology in the region, and also to meet the needs of entrepreneurs and scientists developing important medical device and diagnostic technologies, consumer healthcare products, and pharmaceuticals.
Today’s member video features a case study of a previous Johnson & Johnson Innovation collaboration with Merus Biotherapeutics.
Do you have a video you would like the sector to see? Contact us.